(Q46154968)

English

Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

scientific article published in March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

0 references

1 reference

based on heuristic

inferred from title

author name string

Masatsugu Okishiro

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

Tetsuya Taguchi

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

Seung Jin Kim

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

Kenzo Shimazu

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

Yasuhiro Tamaki

5

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

Shinzaburo Noguchi

6

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

language of work or name

0 references

publication date

1 March 2009

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

115

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

952-961

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

5

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioinformatics research on inter-racial difference in drug metabolism I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of aromatase inhibitors on lipids and thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24111

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24111

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19156902

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46154968&oldid=2095235051"